NCT00000695View on ClinicalTrials.gov

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1991

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Interferon beta-1b

DRUG

Zidovudine

Trial Locations (4)

60611

Northwestern Univ Med School, Chicago

90033

Los Angeles County - USC Med Ctr, Los Angeles

USC School of Medicine / Norris Cancer Hosp, Los Angeles

90095

UCLA CARE Ctr, Los Angeles

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000695 - Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter